BiRD Group Channel

Merc's, about to be launched anti-covid drug, Molnupiravir, awaiting EUA approval by the FDA is causing a huge turmoil in the shares of vaccine manufacturers. The shares of Moderna, Pfizer and Astrazenaca have taken a huge knock after the announcement of the promising preliminary results that the drug, Molnupiravir, according the research head of Merc, reduces mortality and hospitalisation in people infected with the variants.

"Merck COVID-19 pill success slams Moderna shares, shakes up health care sector"

https://www.foxbusiness.com/markets/merck-covid-19-pill-moderna-shares-health-care-sector
The CEO went on to say that the drug can serve as a preventative measure against covid, something that advocates of Ivermectin have been saying all the time because both these drugs are protease inhibitors apart from the fact that ivermectin is also an immuno-modulator besides being a dewormer that costs nothing, with minimal side effects.
The cost of Merc's Molnupiravir will be about R15,000 or $700 for a course of ten tablets. The US has already purchased 1.5 billion of the tablets. Why would they buy such a huge quantity if they were so confident that the vaccine is effective. The oral preparation has had a negative impact on drugs like remdesivir, which have to be administered in a hospital.
Compare the high cost of this drug with ivermectin, which could cost as little as R100 for ten tablets, with a forty year proven safety track record, making it safer than paracetamol or aspirin.
Merc's share value went up considerably after it announced its results and feels confident about its success, as more evidence comes out about the vaccine's dwindling efficacy against the Delta strain, according to the research on 5.1 million people, who have already been vaccinated against the virus.
The high cost of Merc's profit driven drug explains the company's warning about their own drug, Ivermectin without substantiating their claim.
This unsubstantiated claim was used by the Dr Swaminathan, the WHO scientist, who warned India not to use Ivermectin to treat covid infections in a tweet. The Indian Bar Association, lodged a case of disinformation against Dr Swaminathan for misleading the Indian government. Dr Swaminathan immediately retracted her tweet without any scientific explanation or apology, which, apart from being libellous and irresponsible is terribly unscientific and unprofessional.

The failing efficacy of the vaccine has served as a catalyst for Pfizer and Roche to produce their own antiviral drug to gain market share and probably send the vaccine with its attendant side effects and diminishing efficacy to its timely death.

The good news about Merc's new anti-viral is that the frequently requested RCTs for ivermectin can now be conducted without breaking any ethical considerations.

The big question is: will big pharma be willing to pitch their clone of ivermectin against the much maligned but proven drug.

Hopefully, this new drug will give teeth to the clarion call by conscientious scientists throughout the world, who have been calling for an end to the use of this trial drug after it has caused over 40,000 deaths and more than a million adverse events, which only constitutes less than five percent of all the reported cases due to fear and victimisation.
I sincerely hope that all the government agencies in the world and world bodies review their unconstitutional stance to make the vaccines mandatory. If they don't, they should be held accountable for the damage, pain and suffering caused by an experiment that has failed.

Fox Business

Merck COVID-19 pill success slams Moderna shares, shakes up health care sector

Positive clinical trial results for Merck & Co's experimental antiviral COVID-19 pill reverberated through the health care sector on Friday, sending the drugmaker's stock price soaring while denting high-flying shares of vaccine companies and makers of other…

47.8K viewsTessarary, 10:45